SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as news circulates about its acquisition of VLX-1005 and advancements for its lead candidate, tecarfarin, including manufacturing progress and a pivotal Phase 3 trial collaboration with Abbott. The investment community is actively discussing tecarfarin's potential as a next-generation anticoagulant with Fast Track designation for a significant market, yet considerable skepticism persists regarding the company's financial strategy and alleged bot-driven social media activity.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is currently trending on the Solana blockchain, fueled by its strong, culture-first community and the rallying cry of being "like Bitcoin but way higher." The conversation centers on long-term conviction, steady community growth, and the broader global cannabis culture, rather than short-term price movements. Participants express enthusiasm for future developments and sustained positive energy within the ecosystem.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending following news of a multi-billion dollar government investment aimed at securing domestic critical mineral supply chains. This substantial funding, structured as an equity stake and additional financing, has sparked significant community excitement, with many anticipating a considerable increase in valuation and discussing the potential for a short squeeze. The development reinforces broader efforts to establish an integrated mine-to-magnet supply chain and reduce reliance on foreign sources for essential materials.

Tether (USDT) is a cryptocurrency with a value meant to mirror the value of the U.S. dollar. The idea was to create a stable cryptocurrency that can be used like digital dollars. Coins that serve this purpose of being a stable dollar substitute are called “stable coins.” Tether is the most popular stable coin and even acts as a dollar replacement on many popular exchanges! According to their site, Tether converts cash into digital currency, to anchor or “tether” the value of the coin to the price of national currencies like the US dollar, the Euro, and the Yen. Like other cryptos it uses blockchain. Unlike other cryptos, it is [according to the official Tether site] “100% backed by USD” (USD is held in reserve). The primary use of Tether is that it offers some stability to the otherwise volatile crypto space and offers liquidity to exchanges who can’t deal in dollars and with banks (for example to the sometimes controversial but leading exchange Bitfinex).  The digital coins are issued by a company called Tether Limited that is governed by the laws of the British Virgin Islands, according to the legal part of its website. It is incorporated in Hong Kong. It has emerged that Jan Ludovicus van der Velde is the CEO of cryptocurrency exchange Bitfinex, which has been accused of being involved in the price manipulation of bitcoin, as well as tether. Many people trading on exchanges, including Bitfinex, will use tether to buy other cryptocurrencies like bitcoin. Tether Limited argues that using this method to buy virtual currencies allows users to move fiat in and out of an exchange more quickly and cheaply. Also, exchanges typically have rocky relationships with banks, and using Tether is a way to circumvent that.  USDT is fairly simple to use. Once on exchanges like Poloniex or Bittrex, it can be used to purchase Bitcoin and other cryptocurrencies. It can be easily transferred from an exchange to any Omni Layer enabled wallet. Tether has no transaction fees, although external wallets and exchanges may charge one. In order to convert USDT to USD and vise versa through the Tether.to Platform, users must pay a small fee. Buying and selling Tether for Bitcoin can be done through a variety of exchanges like the ones mentioned previously or through the Tether.to platform, which also allows the conversion between USD to and from your bank account.

Tether

Tether (USDT) is trending due to its expanding strategic partnerships, most notably with Rumble, which includes significant ownership, cloud deals, and the rollout of a new Rumble Wallet enabling crypto payments for creators. The community is actively discussing how these integrations and Tether's substantial financial strength are driving broader crypto utility within the creator economy and AI infrastructure.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

TRON is trending due to its recent integration with Coinbase's Base network and reports of Tether freezing funds on Tron wallets, driving varied community discussion. Sentiment is split between those who see strong utility and growth in its stablecoin transactions, and critics raising concerns about centralization and past manipulation. The ongoing narrative around Tron's cloud deals and payment options through platforms like Rumble also contributes to its visibility.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending amidst heightened community discussion surrounding major financial institutions expanding their crypto ETF offerings and reports of potential favorable legislation impacting digital assets. Investors are actively debating Bitcoin's price trajectory, with conversations focused on reclaiming key levels and its evolving role in a shifting global financial landscape.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending amid a leadership transition to new CEO Tom Stepien and community discussion over recent insider share sales, which are fueling market volatility. Investors are keenly focused on the company's high-performance battery technology, poised for significant growth within the expanding defense and drone sectors, with further speculation around potential partnerships with Amazon's aerospace programs.

ARK Investment Management LLC - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is a major talking point, with its chart showing breakout potential and some community members anticipating strong upward movement fueled by momentum and story catalysts. This comes as Cathie Wood actively rebalances the portfolio, making notable sales in Tesla while adding to positions in various disruptive companies, including Netflix, DraftKings, Klarna, and biotech names. However, sentiment remains divided, with bullish outlooks on innovation clashing against skepticism regarding sustained performance in high-growth sectors and institutional short interest.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is experiencing significant market attention and a notable rally ahead of its highly anticipated earnings report, with much of the community expressing bullish sentiment regarding its AI investments and monetization efforts for platforms like Threads and WhatsApp. While many see the stock as undervalued compared to its tech peers, others express caution, citing substantial capital expenditures in AI with unproven returns and drawing parallels to past metaverse spending.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid extensive community discussion surrounding its pivotal partnership with Tether, which includes significant financial commitments for advertising and cloud services, and the recent Northern Data acquisition set to dramatically expand its AI cloud infrastructure. Investors are highlighting Tether's increasing ownership and Rumble's new crypto wallet as key growth drivers, while also pointing to record short interest and high borrowing costs as fuel for potential market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average - Here's What Happened

Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above Two Hundred Day Moving Average - Time to Sell...

Achieve Life Sciences Promotes Mark Rubinstein As Chief Medical Officer

(RTTNews) - Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company, said Monday it has confirmed the promotion of Mark Rubinstein from Interim Chief Medical Officer to...

Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average - Here's Why

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...

<p>Hunterbrook Capital on Tuesday revealed it is long on Achieve Life Sciences (ACHV) stock as the company nears a green light from the U.S. Food and Drug Administration for Cytisinicline as a treatment for smoking addiction.</p><p>The FDA is expected to rule on Achieve Life Sciences’ application seeking approval for the drug by June 20, 2026. If approved, the company plans to sell it in the U.S. by the end of the year.</p><p>Hunterbrook Media <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://hntrbrk.com/achieve/">said</a> that Cytisinicline is already used in Europe and added that smoking cessation clinicians, scientists, and health program directors that it interviewed recommended approval in the U.S.</p><p>The report also noted that Cytisinicline has proven safer and more effective than its predecessors including Pfizer’s Chantix and GlaxoSmithKline’s Zyban. Chantix, despite side effects, earned over $1 billion in peak annual sales and it, like GSK’s Zyban, also required longer treatment than Cytisinicline, the firm said.</p><p>Furthermore, despite smoking being on the decline, it is still rampant, the firm noted.</p><p>There are about 29 million American cigarette smokers and about 28 million e-cigarette users, including many middle and high schoolers, the firm said. While about a half of this population try to quit, only a small portion succeeds.</p><h2 class="st-heading-2">FDA Priority Review Voucher</h2><p>The FDA awarded Achieve a Commissioner's National Priority Voucher (CNPV) aimed at expediting review for Cytisinicline in October. “It's been nearly two decades since a new treatment option for smoking cessation was approved, and there are currently no treatment options for vaping cessation,” Achieve CEO Rick Stewart said then.</p><h2 class="st-heading-2">Hunterbrook Flags Potential Headwinds</h2><p>“As with all applications, the FDA could still require additional data or studies if any safety concerns arise. Achieve also needs to maintain long-term access to cytisinicline supply. &nbsp;The company is in a legal dispute with its original supplier, Sopharma, though Achieve named other suppliers in its FDA application,” Hunterbrook said.</p><p>The firm also flagged funding concerns, highlighting that while Achieve is funded through the second quarter of 2026, it will need to raise more capital to commercialize the drug after receiving approval.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>ACHV stock traded 7% higher at the time of writing. On Stocktwits, retail sentiment around ACHV jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to 'normal' levels.</p><p><a href="https://stocktwits.com/symbol/ACHV">ACHV stock</a> has gained 34% this year and by about 31% over the past 12 months.&nbsp;</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/walmart-app-website-down-for-users-amid-new-year-shopping-rush/cL7I4vlREyI">Walmart App And Website Down For Users Amid New Year Shopping Rush</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

In this photo illustration, the Achieve Life Sciences logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Achieve Life Sciences’ Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook

The FDA is expected to rule on Achieve Life Sciences’ application seeking approval for the drug by June 20, 2026.

Equity

Achieve Life Sciences (NASDAQ:ACHV) Shares Cross Above Two Hundred Day Moving Average - Here's Why

Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average - What's Next...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Rating of "Moderate Buy" by Analysts

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five brokerages that are covering the stock, MarketBeat Ratings reports...

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell?

Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above 200-Day Moving Average - Time to Sell...

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week PR Newswire SEATTLE...

Achieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell...

Stonepine Capital Management LLC Takes Position in Achieve Life Sciences, Inc. $ACHV

Stonepine Capital Management LLC acquired a new stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) in the 2nd quarter, according to the company in its most recent disclosure...

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Achieve Life Sciences Inc.

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

ACHV
Achieve Life Sciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ACHV News

ACHVAchieve Life Sciences Inc.